Oxycodone and Aspirin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Oxycodone Hydrochloride; Aspirin.
Product ID | 0591-3551_0c3167ea-b863-485b-b18e-e7835803c9cb |
NDC | 0591-3551 |
Product Type | Human Prescription Drug |
Proprietary Name | Oxycodone and Aspirin |
Generic Name | Oxycodone And Aspirin |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2011-10-18 |
Marketing End Date | 2020-06-30 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA090084 |
Labeler Name | Actavis Pharma, Inc. |
Substance Name | OXYCODONE HYDROCHLORIDE; ASPIRIN |
Active Ingredient Strength | 5 mg/1; mg/1 |
Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
DEA Schedule | CII |
NDC Exclude Flag | N |
Marketing Start Date | 2011-10-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA090084 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-10-18 |
Marketing End Date | 2020-06-30 |
Ingredient | Strength |
---|---|
OXYCODONE HYDROCHLORIDE | 4.8355 mg/1 |
SPL SET ID: | a598f735-d2e2-43ad-be77-8627ea4a9b78 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
Pharm Class PE | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0591-3551 | Oxycodone and Aspirin | Oxycodone and Aspirin |
68308-845 | Oxycodone and Aspirin | Oxycodone Hydrochloride and Aspirin |